Brookfield Corp’s Medtronic MDT Stock Holding History

Brookfield Corp’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-6,854	Closed	-$604K	–	366
2023 Q2	$604K	Buy	6,854 +837	+14%	+$72.1K	﹤0.01%	492
2023 Q1	$485K	Buy	+6,017	New	+$490K	﹤0.01%	577
2022 Q4	–	Sell	-285,359	Closed	-$23M	–	683
2022 Q3	$23M	Buy	285,359 +255,726	+863%	+$23M	0.08%	88
2022 Q2	$2.66M	Buy	+29,633	New	+$3M	0.01%	359
2021 Q4	–	Sell	-116,588	Closed	-$14.6M	–	698
2021 Q3	$14.6M	Buy	+116,588	New	+$15.1M	0.06%	104
2021 Q2	–	Sell	-48,487	Closed	-$5.73M	–	608
2021 Q1	$5.73M	Buy	48,487 +16,798	+53%	+$1.97M	0.03%	155
2020 Q4	$3.71M	Sell	31,689 -28,352	-47%	-$3.12M	0.02%	204
2020 Q3	$6.24M	Buy	60,041 +36,451	+155%	+$3.66M	0.03%	127
2020 Q2	$2.16M	Buy	+23,590	New	+$2.26M	0.01%	208

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Brookfield Corp's MDT Position: Q3 2023 in Review

Brookfield Corp sold out of Medtronic (MDT) in Q3 2023, closing a stake of 6,854 shares — an estimated $604K sold.

Brookfield Corp first reported a position in MDT in Q2 2020 and held it in 9 quarters. The position peaked at $23M in Q3 2022. 1,971 funds tracked by Wall St. Rank hold MDT as of Q3 2023.

Brookfield Corp reported no remaining Medtronic position as of Q3 2023 after selling out during the quarter.
Brookfield Corp sold 6,854 Medtronic shares in Q3 2023, an estimated $604K.
Brookfield Corp first reported a position in Medtronic in Q2 2020 and held it in 9 quarters.
Brookfield Corp's Medtronic position peaked at $23M in Q3 2022.
1,971 funds tracked by Wall St. Rank held Medtronic as of Q3 2023.

Based on Brookfield Corp's 13F filing for Q3 2023, filed 14 Nov 2023.